EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies

Hiroto Takeuchi, Chie Nakajima, Satoru Konnai iD, Naoya Maekawa, Tomohiro Okagawa iD, Masaru Usui, Yutaka Tamura, Yasuhiko Suzuki iD, Shiro Murata, Kazuhiko Ohashi

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Hiroto Takeuchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Staphylococcus aureus, Coagulase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, National Agriculture and Food Research Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coagulase-positive Staphylococci express protein A, which binds to host antibodies, to evade the immune system. Taking advantage of its specific binding to antibodies, protein A from Staphylococcus aureus , which is called SpA, is commonly used as an affinity chromatography ligand for human therapeutic antibodies. However, among four canine IgG subclasses (A, B, C, and D), only IgG-B binds to SpA strongly and establishing an efficient and robust purification scheme for canine therapeutic antibodies whose IgG subclass is A, C, or D remains difficult and depends on finding a suitable substitute to SpA. S . pseudintermedius , a major coagulase-positive Staphylococci found in dogs, expresses spsQ gene which is orthologous to S . aureus spa . We hypothesized that to serve S . pseudintermedius to better adapt to the dog immune system, SpsQ would bind to canine IgGs stronger than SpA, making it a better affinity chromatography ligand for canine therapeutic antibodies. To characterize SpsQ, we first determined the spsQ nucleotide sequence from S . pseudintermedius isolates. Based on the identified sequence, we prepared recombinant proteins containing the immunoglobulin-binding domains of SpA (r-SpA) and SpsQ (r-SpsQ) and determined their binding capacity for each canine IgG subclass. The binding capacity of r-SpsQ for IgG-B was almost as high as that of r-SpA. Interestingly, while both r-SpsQ and r-SpA showed no binding to IgG-C, the binding capacity of r-SpsQ for IgG-A and IgG-D was significantly higher than that of r-SpA. Finally, we performed affinity chromatography using r-SpsQ- or r-SpA-immobilized resin and revealed that the recovery rates of IgG-A and IgG-D using r-SpsQ were significantly higher than those using r-SpA. Our findings indicate that SpsQ has a strong potential to be used as an affinity chromatography ligand for canine therapeutic antibodies of subclass A, B, and D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusCoagulaseChromatography, AffinityDogsImmunoglobulin GAnimalsImmunologic FactorsLigandsStaphylococcal Protein AStaphylococcus

Substanzen

CoagulaseImmunoglobulin GImmunologic FactorsLigandsStaphylococcal Protein A

Autor:innen und Institutionen

  • Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan.
  • Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.
  • Division of Bioresources, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.
  • Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
  • Faculty of Veterinary Medicine, International Affairs Office, Hokkaido University, Sapporo, Japan.

ORCID-Profile: Satoru Konnai, Tomohiro Okagawa, Yasuhiko Suzuki

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • National Agriculture and Food Research Organization

Zitieren

APA

Takeuchi, H., Nakajima, C., Konnai, S., Maekawa, N., Okagawa, T., Usui, M., Tamura, Y., Suzuki, Y., Murata, S., & Ohashi, K. (2023). Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies. PLOS ONE. https://doi.org/10.1371/journal.pone.0281171

Vancouver

Takeuchi H, Nakajima C, Konnai S, Maekawa N, Okagawa T, Usui M, et al. Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies. PLOS ONE. 2023. doi:10.1371/journal.pone.0281171

BibTeX
@article{Takeuchi2023,
  author = {Takeuchi, Hiroto and Nakajima, Chie and Konnai, Satoru and Maekawa, Naoya and Okagawa, Tomohiro and Usui, Masaru and Tamura, Yutaka and Suzuki, Yasuhiko and Murata, Shiro and Ohashi, Kazuhiko},
  title = {Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281171}
}
Kostenlos starten →